OpenVSafe by OpenVAERS
Search V-safe

WUH-12011-54739

4 vaccinations 1 coded response 15 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
276 / NC
Registered
2021-03-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
SRB-23132-37076 Child or adolescent in my care · Male · 2022-07-01

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2548994 (opens in a new window) high 10 / 11 2 4 of 9 VAERS symptoms same dose (4) NC matches 2022-10-03 / 2022-12-19 / 2023-01-03
received the same day as the last call
case 5536

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-03
    Registered in v-safe
  2. 2021-03-09
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-30
    Dose 2 — Pfizer-BioNTech
  4. 2021-03-30
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-03-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  8. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-06
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-10-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-11-30
    Dose 3 — Pfizer-BioNTech
  17. 2022-03-30
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-10-03
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  19. 2023-01-02
    Survey response — 3 months, dose 4
    MedDRA: COVID-19, Oropharyngeal pain, Pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  20. 2023-01-02
    Report sent to call center — 3 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  21. 2023-01-03
    Call successful
    Completed over the phone
  22. 2023-04-03
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Pfizer-BioNTech
22021-03-30Pfizer-BioNTech
32021-11-30Pfizer-BioNTech No
42022-10-03Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2023-01-02 Successful
2023-01-03
Completed over the phone

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release